CAS : 54965-24-1
Molecular Formula : C32H37NO8
Formula Weight : 563.64
Tamoxifen citrate is approved by the Food and Drug Administration (FDA) to treat breast cancer in women and men. Tamoxifen is also approved to decrease the chance of developing breast cancer in women who are at high risk for this disease. Tamoxifen citrate is also being studied in the treatment of other types of cancer.
Product Categories: Active Pharmaceutical Ingredients;Antitumors for Research and Experimental Use;Biochemistry;API's;Intracellular receptor
mp: 140-144 °C
storage temp: 2-8°C
Water Solubility : slightly soluble
Risk Statements : 45-60-61-22-64-36/37/38
Safety Statements: 53-36/37/39-45-36-26
Chemical Properties :white to off-white powder
Send enquiry online
After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
Tel: +86 592 5365868
WhatsApp: +86 189 6516 2351